| ADAPTIVE BIOTECHNOLOGIES |
| USA |
| Gesundheit |
| US00650F1093 / A2PLR5 |
| 1HM (Frankfurt) / ADPT (NASDAQ) |
| FRA:1HM, ETR:1HM, 1HM:GR, NASDAQ:ADPT |
| - |
| https://www.adaptivebiote.. |
|
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company that develops an immune medicine platform for diagnosing and treating various diseases. The company's core offering is its immunosequencing platform, which uses propriet..
>Volltext.. |
| 2343.27 Mio. EUR |
| 2341.32 Mio. EUR |
| 257.76 Mio. EUR |
| -25.13 Mio. EUR |
| -43.35 Mio. EUR |
| -0.28 EUR |
| 181.65 Mio. EUR |
| 67.69 Mio. EUR |
| -23.59 Mio. EUR |
| 2.51 |
| 45.95% |
| 67.2% |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.507.645 Euro. |
| ADAPTIVE BIOTECHNOLOGIES, ADAPTIVE BIO, ADAPTIVE BIOTECH |
| 20.06.26 |
|